News
Around the world in 24 hours: A snapshot of COVID’s global havoc
October 26, 2020
Some medical societies feature sessions at their annual meetings that feel like they’re 24 hours long, yet few have the courage to schedule a session that runs all day and all night.
News
Unneeded meds at discharge could cause harm
October 26, 2020
The problem stems from a technology disconnect when patients are transferred from the ICU to the general population.
News
Score predicts risk for ventilation in COVID-19 patients
October 23, 2020
“If mild COVID disease in young patients caused cardiac injury, you can imagine what it can do to older patients with severe disease,” Dr. Alnababteh said.
News
Trump and Biden face off over COVID-19, ACA in final debate
October 23, 2020
The adequacy of the COVID-19 response to date, the likely timeline for vaccine availability, and how to reopen businesses were among the points on which the two candidates disagreed.
News
When should students resume sports after a COVID-19 diagnosis?
October 23, 2020
While many patients will be ready to gradually return to play after quarantining, cardiac symptoms should prompt additional evaluation.
News
No mortality benefit after intensive glucose control once Hb A1c curves equalize
October 23, 2020
Is there a reduction in cardiovascular events in veterans with type 2 diabetes who were treated with intensive glucose control versus standard therapy at 15 years’ follow-up?
News
COVID-19 vaccine standards questioned at FDA advisory meeting
October 23, 2020
Speakers asked for data showing COVID-19 vaccines can prevent serious illness and urged transparency about the agency’s deliberations for each product to be considered.
News
CDC expands definition of COVID-19 exposure from ‘close contact’
October 23, 2020
Four factors associated with higher risk for transmission are the proximity of each encounter, its duration, whether an interaction takes place indoors or outdoors, and the number of people encountered.
News
COVID-19: Convalescent plasma falls short in phase 2 trial
October 22, 2020
Convalescent plasma may reduce viral load, hospital stay, and mortality, but randomized controlled trials to date have ended prematurely.
News
FDA approves remdesivir, first treatment for COVID-19
October 22, 2020
The FDA also issued a new EUA for remdesivir allowing treatment of hospitalized pediatric patients younger than 12 weighing at least 3.5 kg.